<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34549199</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2666-3546</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Brain, behavior, &amp; immunity - health</Title><ISOAbbreviation>Brain Behav Immun Health</ISOAbbreviation></Journal><ArticleTitle>Post-acute sequelae of COVID-19: Evidence of mood &amp; cognitive impairment.</ArticleTitle><Pagination><StartPage>100347</StartPage><MedlinePgn>100347</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100347</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbih.2021.100347</ELocationID><Abstract><AbstractText>Acute health consequences associated with coronavirus disease 2019 (COVID-19) infection have been thoroughly characterized; however, long-term impacts are not yet understood. Post-acute sequelae of COVID-19 (PASC), also known as Long COVID syndrome, is the persistence of COVID-19 symptoms long after viral infection. In addition to physical symptoms, those with PASC experience changes in mental health, but few studies have empirically examined these effects. The current study investigated mood and cognitive functioning in individuals who have recovered from COVID-19 infection. We recruited 100 male and female adults (M&#xa0;&#x200b;=&#xa0;&#x200b;30 years old) with no history of mood or cognitive impairment prior to the COVID-19 pandemic (Jan. 2020). Half of the subjects were healthy controls (i.e., no prior COVID-19 infection) and half had received a past COVID-19 diagnosis (ascertained by PCR or antibody test) but were no longer infectious. Participants completed self-reported measures of stress, depression, and anhedonia, as well as the Attention Network Test (ANT), a behavioural measure of attentional alerting, orienting and executive functioning. Relative to controls, depression and anhedonia were significantly higher in the past-COVID group. Selective impairment in attention was observed in the past-COVID group, marked by deficits in executive functioning while alerting and orienting abilities remained intact. Effects were most pronounced among individuals diagnosed 1-4 months prior to assessment. There were no group differences in pandemic-related experiences with respect to social interaction, social distancing, or isolation. The past-COVID group scored significantly higher on perceived stress; however, this did not moderate any effects observed on mood or cognition. These findings implicate a protracted reaction to the virus, possibly via prolonged inflammation, contributing to sustained mood dysregulation and cognitive impairment. Future research should examine the neural and physiological underpinnings of PASC, particularly mechanisms that promote psychiatric sequelae 1-4 months following diagnosis.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lamontagne</LastName><ForeName>Steven J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Psychology, Queen's University, Kingston, Ontario, K7L 3N6, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Depression, Anxiety and Stress Research, McLean Hospital/Harvard Medical School, Belmont, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winters</LastName><ForeName>Makaila F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Psychology, Queen's University, Kingston, Ontario, K7L 3N6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pizzagalli</LastName><ForeName>Diego A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Center for Depression, Anxiety and Stress Research, McLean Hospital/Harvard Medical School, Belmont, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McLean Imaging Center, McLean Hospital, Belmont, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olmstead</LastName><ForeName>Mary C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Psychology, Queen's University, Kingston, Ontario, K7L 3N6, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Neuroscience Studies, Queen's University, Kingston, Ontario, K7L 3N6, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MH095809</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 MH068376</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Behav Immun Health</MedlineTA><NlmUniqueID>101759062</NlmUniqueID><ISSNLinking>2666-3546</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anhedonia</Keyword><Keyword MajorTopicYN="N">Attention network test (ANT)</Keyword><Keyword MajorTopicYN="N">Cognitive control</Keyword><Keyword MajorTopicYN="N">Coronavirus disease 2019 (COVID-19)</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Long haul COVID</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of COVID-19 (PASC)</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">depression</Keyword></KeywordList><CoiStatement>SJL, MFW, and MCO declare no competing interests. Over the past 3 years, DAP has received consulting fees from BlackThorn Therapeutics, Boehringer Ingelheim, Compass Pathway, Concert Pharmaceuticals, Engrail Pharmaceuticals, Otsuka Pharmaceuticals, and Takeda Pharmaceuticals; one honorarium from Alkermes, and research funding from the 10.13039/100000025National Institute of Mental Health (NIMH), 10.13039/100001068Dana Foundation, 10.13039/100000874Brain and Behavior Research Foundation, Millennium Pharmaceuticals. In addition, he has received stock options from BlackThorn Therapeutics. No funding from these entities was used to support the current work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>22</Day><Hour>7</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34549199</ArticleId><ArticleId IdType="pmc">PMC8437695</ArticleId><ArticleId IdType="doi">10.1016/j.bbih.2021.100347</ArticleId><ArticleId IdType="pii">S2666-3546(21)00150-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alonso-Lana S., Marqui&#xe9; M., Ruiz A., Boada M. Cognitive and neuropsychiatric manifestations of COVID-19 and effects on elderly individuals with dementia. Front. Aging Neurosci. 2020;12:588872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7649130</ArticleId><ArticleId IdType="pubmed">33192483</ArticleId></ArticleIdList></Reference><Reference><Citation>Ardila A., Lahiri D. Executive dysfunction in COVID-19 patients. Diabetes &amp; Metabolic Syndrome. 2020;14(5):1377&#x2013;1378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7373676</ArticleId><ArticleId IdType="pubmed">32755837</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M. Neurological manifestations in COVID-19 caused by SARS-CoV-2. CNS Neurosci. Ther. 2020;26(5):499&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7163592</ArticleId><ArticleId IdType="pubmed">32266761</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M., Sanders E.C. Potential neuroinvasive pathways of SARS-CoV-2: deciphering the spectrum of neurological deficit seen in coronavirus disease-2019 (COVID-19) J.&#xa0;Med. Virol. 2020;92(10):1845&#x2013;1857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300748</ArticleId><ArticleId IdType="pubmed">32492193</ArticleId></ArticleIdList></Reference><Reference><Citation>Batty G.D., Deary I.J., Luciano M., Altschul D.M., Kivim&#xe4;ki M., Gale C.R. Psychosocial factors and hospitalisations for COVID-19: prospective cohort study based on a community sample. Brain Behav. Immun. 2020;89:569&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7297693</ArticleId><ArticleId IdType="pubmed">32561221</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck A.T., Steer R.A., Brown G.K. The Psychological Corporation, Harcourt Brace; Toronto: 1996. Beck Depression Inventory-II (BDI-II)</Citation></Reference><Reference><Citation>Benedetti F., Mazza M., Cavalli G., Ciceri F., Dagna L., Rovere-Querini P. Can cytokine blocking prevent depression in COVID-19 survivors? J.&#xa0;Neuroimmune Pharmacol. 2021;16(1):1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7587545</ArticleId><ArticleId IdType="pubmed">33107012</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldrini M., Canoll P.D., Klein R.S. How COVID-19 affects the brain. JAMA psychiatry. 2021 doi: 10.1001/jamapsychiatry.2021.0500. Published online March 26, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2021.0500</ArticleId><ArticleId IdType="pmc">PMC9894299</ArticleId><ArticleId IdType="pubmed">33769431</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. J.&#xa0;Am. Med. Assoc. 2020;324(6):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention Discontinuation of isolation for persons with COVID-19 not in healthcare settings. 2021. https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html Accessed.</Citation></Reference><Reference><Citation>Chapman L.J., Chapman J.P. The measurement of handedness. Brain Cognit. 1987;6(2):175&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pubmed">3593557</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S., Kamarck T., Mermelstein R. A&#xa0;global measure of perceived stress. J.&#xa0;Health Soc. Behav. 1983;24:385&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pubmed">6668417</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortinovis M., Perico N., Remuzzi G. Long-term follow-up of recovered patients with COVID-19. Lancet. 2021;397(10270):173&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833833</ArticleId><ArticleId IdType="pubmed">33428868</ArticleId></ArticleIdList></Reference><Reference><Citation>De La Garza R., II Endotoxin-or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia. Neurosci. Biobehav. Rev. 2005;29(4&#x2013;5):761&#x2013;770.</Citation><ArticleIdList><ArticleId IdType="pubmed">15878621</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle D.M., Kim-Schulze S., Huang H.H., Beckmann N.D., Nirenberg S., Wang B. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 2020;26(10):1636&#x2013;1643.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Derryberry D., Reed M.A. Anxiety-related attentional biases and their regulation by attentional control. J.&#xa0;Abnorm. Psychol. 2002;111(2):225&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pubmed">12003445</ArticleId></ArticleIdList></Reference><Reference><Citation>Dillon D.G., Pizzagalli D.A. Evidence of successful modulation of brain activation and subjective experience during reappraisal of negative emotion in unmedicated depression. Psychiatr. Res. Neuroimaging. 2013;212(2):99&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3640775</ArticleId><ArticleId IdType="pubmed">23570916</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudek K.A., Dion-Albert L., Lebel M., LeClair K., Labrecque S., Tuck E. Molecular adaptations of the blood&#x2013;brain barrier promote stress resilience vs. depression. Proc. Natl. Acad. Sci. Unit. States Am. 2020;117(6):3326&#x2013;3336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7022213</ArticleId><ArticleId IdType="pubmed">31974313</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenberger N.I., Berkman E.T., Inagaki T.K., Rameson L.T., Mashal N.M., Irwin M.R. Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol. Psychiatr. 2010;68(8):748&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3025604</ArticleId><ArticleId IdType="pubmed">20719303</ArticleId></ArticleIdList></Reference><Reference><Citation>El Sayed S., Shokry D., Gomaa S.M. Post-COVID-19 fatigue and anhedonia: a cross-sectional study and their correlation to post-recovery period. Neuropsychopharmacology Reports. 2021;41(1):50&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8182964</ArticleId><ArticleId IdType="pubmed">33332756</ArticleId></ArticleIdList></Reference><Reference><Citation>Epp A.M., Dobson K.S., Dozois D.J., Frewen P.A. A&#xa0;systematic meta-analysis of the Stroop task in depression. Clin. Psychol. Rev. 2012;32(4):316&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pubmed">22459792</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan J., McCandliss B.D., Sommer T., Raz A., Posner M.I. Testing the efficiency and independence of attentional networks. J.&#xa0;Cognit. Neurosci. 2002;14(3):340&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pubmed">11970796</ArticleId></ArticleIdList></Reference><Reference><Citation>Harkness A., Behar-Zusman V., Safren S.A. Understanding the impact of COVID-19 on Latino sexual minority men in a US HIV hot spot. AIDS Behav. 2020;24(7):2017&#x2013;2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7160054</ArticleId><ArticleId IdType="pubmed">32300989</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes A.J., Pizzagalli D.A. Response conflict and frontocingulate dysfunction in unmedicated participants with major depression. Neuropsychologia. 2008;46(12):2904&#x2013;2913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2538441</ArticleId><ArticleId IdType="pubmed">18577391</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp J.A., Dressing A., Blazhenets G., Bormann T., Rau A., Schwabenland M., Meyer P.T. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021 doi: 10.1093/brain/awab009. Published April 03, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab009</ArticleId><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Ironside M., Admon R., Maddox S.A., Mehta M., Douglas S., Olson D.P., Pizzagalli D.A. Inflammation and depressive phenotypes: evidence from medical records from over 12 000 patients and brain morphology. Psychol. Med. 2020;50(16):2790&#x2013;2798.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7160032</ArticleId><ArticleId IdType="pubmed">31615590</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaywant A., Vanderlind W.M., Alexopoulos G.S., Fridman C.B., Perlis R.H., Gunning F.M. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology. 2021 doi: 10.1038/s41386-021-00978-8. Published online February 15, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-021-00978-8</ArticleId><ArticleId IdType="pmc">PMC7884062</ArticleId><ArticleId IdType="pubmed">33589778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kujawa A., Green H., Compas B.E., Dickey L., Pegg S. Exposure to COVID-19 pandemic stress: associations with depression and anxiety in emerging adults in the United States. Depress. Anxiety. 2020;37(12):1280&#x2013;1288.</Citation><ArticleIdList><ArticleId IdType="pubmed">33169481</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne S.J., Pizzagalli D.A., Olmstead M.C. Does inflammation link stress to poor COVID-19 outcome? Stress Health. 2020 doi: 10.1002/smi.3017. Published online December 14, 2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/smi.3017</ArticleId><ArticleId IdType="pubmed">33315291</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak I.W.C., Chu C.M., Pan P.C., Yiu M.G.C., Chan V.L. Long-term psychiatric morbidities among SARS survivors. Gen. Hosp. Psychiatr. 2009;31(4):318&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112501</ArticleId><ArticleId IdType="pubmed">19555791</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Brill S.E., Brown J.S., Denneny E.K., Hare S.S. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., L&#xfc;tgehetmann M., Hagel C., Sperhake J.P., Schr&#xf6;der A.S., Edler C. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., De Lorenzo R., Conte C., Poletti S., Vai B., Bollettini I. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav. Immun. 2020;89:594&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>McEwen B.S., Sapolsky R.M. Stress and cognitive function. Curr. Opin. Neurobiol. 1995;5(2):205&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">7620309</ArticleId></ArticleIdList></Reference><Reference><Citation>Menard C., Pfau M.L., Hodes G.E., Kana V., Wang V.X., Bouchard S. Social stress induces neurovascular pathology promoting depression. Nat. Neurosci. 2017;20(12):1752&#x2013;1760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5726568</ArticleId><ArticleId IdType="pubmed">29184215</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriguchi T., Harii N., Goto J., Harada D., Sugawara H., Takamino J. A&#xa0;first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int. J. Infect. Dis. 2020;94:55&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195378</ArticleId><ArticleId IdType="pubmed">32251791</ArticleId></ArticleIdList></Reference><Reference><Citation>Mould K.J., Janssen W.J. Signs of self-sustained inflammatory circuits in severe COVID pneumonia. Nature. 2021;590:553&#x2013;554.</Citation><ArticleIdList><ArticleId IdType="pubmed">33558748</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>NIH (2021). Accessed Apr 28 2021. https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-launches-new-initiative-study-long-covid.</Citation></Reference><Reference><Citation>Osimo E.F., Baxter L.J., Lewis G., Jones P.B., Khandaker G.M. Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels. Psychol. Med. 2019;49(12):1958&#x2013;1970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6712955</ArticleId><ArticleId IdType="pubmed">31258105</ArticleId></ArticleIdList></Reference><Reference><Citation>Paz C., Mascialino G., Adana-D&#xed;az L., Rodr&#xed;guez-Lorenzana A., Simba&#xf1;a-Rivera K., G&#xf3;mez-Barreno L. Anxiety and depression in patients with confirmed and suspected COVID-19 in Ecuador. Psychiatr. Clin. Neurosci. 2020;74(10):554&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361296</ArticleId><ArticleId IdType="pubmed">32609409</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzagalli D.A. Depression, stress, and anhedonia: toward a synthesis and integrated model. Annu. Rev. Clin. Psychol. 2014;10:393&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3972338</ArticleId><ArticleId IdType="pubmed">24471371</ArticleId></ArticleIdList></Reference><Reference><Citation>Puchner B., Sahanic S., Kirchmair R., Pizzini A., Sonnweber B., W&#xf6;ll E., M&#xfc;hlbacher A., Garimorth K., Dareb B., Ehling R., Wenter J., Schneider S., Brenneis C., Weiss G., Tancevski I., Sonnweber T., L&#xf6;ffler-Ragg J. Beneficial effects of multi-disciplinary rehabilitation in post-acute COVID-19 &#x2013; an observational cohort study. Eur. J. Phys. Rehabil. Med. 2021;15:2021. doi: 10.23736/s1973-9087.21.06549-7. Published online January.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/s1973-9087.21.06549-7</ArticleId><ArticleId IdType="pubmed">33448756</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhea E.M., Logsdon A.F., Hansen K.M., Williams L.M., Reed M.J., Baumann K.K. The S1 protein of SARS-CoV-2 crosses the blood&#x2013;brain barrier in mice. Nat. Neurosci. 2021;24(3):368&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8793077</ArticleId><ArticleId IdType="pubmed">33328624</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J.P., Chesney E., Oliver D., Pollak T.A., McGuire P., Fusar-Poli P. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. The Lancet Psychiatry. 2020;7(7):611&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossetti A.C., Papp M., Gruca P., Paladini M.S., Racagni G., Riva M.A., Molteni R. Stress-induced anhedonia is associated with the activation of the inflammatory system in the rat brain: restorative effect of pharmacological intervention. Pharmacol. Res. 2016;103:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">26535964</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo S., Menard C., Pfau M., Hodes G., Kana V., Wang V. Social stress induces neurovascular pathology promoting immune infiltration and depression. Biol. Psychiatr. 2018;83(9):S36.</Citation></Reference><Reference><Citation>Saleki K., Banazadeh M., Saghazadeh A., Rezaei N. The involvement of the central nervous system in patients with COVID-19. Rev. Neurosci. 2020;31(4):453&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pubmed">32463395</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A.S., Wong A.W., Hague C.J., Murphy D.T., Johnston J.C., Ryerson C.J., Carlsten C. A&#xa0;prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax. 2021;76(4):402&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pubmed">33273023</ArticleId></ArticleIdList></Reference><Reference><Citation>Snaith R.P., Hamilton M., Morley S., Humayan A., Hargreaves D., Trigwell P. A&#xa0;scale for the assessment of hedonic tone the Snaith&#x2013;Hamilton Pleasure Scale. Br. J. Psychiatr. 1995;167(1):99&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">7551619</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommerfeldt S.L., Cullen K.R., Han G., Fryza B.J., Houri A.K., Klimes-Dougan B. Executive attention impairment in adolescents with major depressive disorder. J.&#xa0;Clin. Child Adolesc. Psychol. 2016;45(1):69&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4731238</ArticleId><ArticleId IdType="pubmed">26566871</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. The Lancet Psychiatry. 2021;8(5):416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Luciano S., Geddes J.R., Harrison P.J. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. The Lancet Psychiatry. 2021;8(2):130&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Toniolo S., Di Lorenzo F., Scarioni M., Frederiksen K.S., Nobili F. Is the frontal lobe the primary target of SARS-CoV-2? J.&#xa0;Alzheim. Dis. 2021 doi: 10.3233/JAD-210008. Published online January 01, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-210008</ArticleId><ArticleId IdType="pubmed">33720900</ArticleId></ArticleIdList></Reference><Reference><Citation>Treadway M.T., Admon R., Arulpragasam A.R., Mehta M., Douglas S., Vitaliano G. Association between interleukin-6 and striatal prediction-error signals following acute stress in healthy female participants. Biol. Psychiatr. 2017;82(8):570&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5610086</ArticleId><ArticleId IdType="pubmed">28506437</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson D., Weber K., Assenheimer J.S., Clark L.A., Strauss M.E., McCormick R.A. Testing a tripartite model: evaluating the convergent and discriminant validity of anxiety and depression symptom scales. J.&#xa0;Abnorm. Psychol. 1995;104(1):3&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">7897050</ArticleId></ArticleIdList></Reference><Reference><Citation>Welcome M.O., Mastorakis N.E. Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection. Inflammopharmacology. 2021 doi: 10.1007/s10787-021-00806-x. Published online April 06, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-021-00806-x</ArticleId><ArticleId IdType="pmc">PMC8021940</ArticleId><ArticleId IdType="pubmed">33822324</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Zhong S., Liu J., Li L., Li Y., Wu X. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin. Infect. Dis. 2005;41(8):1089&#x2013;1096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7107994</ArticleId><ArticleId IdType="pubmed">16163626</ArticleId></ArticleIdList></Reference><Reference><Citation>Zalli A., Jovanova O., Hoogendijk W.J.G., Tiemeier H., Carvalho L.A. Low-grade inflammation predicts persistence of depressive symptoms. Psychopharmacology. 2016;233(9):1669&#x2013;1678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4828485</ArticleId><ArticleId IdType="pubmed">25877654</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>